Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage (Q46213460)

20 December 2017

title

Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage (English)

1 reference

20 December 2017

author name string

Yoshitomo Notsu

1

1 reference

20 December 2017

Toru Nabika

2

1 reference

20 December 2017

Hirokazu Bokura

3

1 reference

20 December 2017

Yoji Suyama

4

1 reference

20 December 2017

Shotai Kobayashi

5

1 reference

20 December 2017

Schuhei Yamaguchi

6

1 reference

20 December 2017

Junichi Masuda

7

1 reference

20 December 2017

publication date

4 December 2008

1 reference

20 December 2017

Journal of Clinical Hypertension

published in

1 reference

20 December 2017

volume

22

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

257-262

1 reference

20 December 2017

Risk factors for microangiopathy-related cerebral damage in the Austrian stroke prevention study

cites work

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Carotid artery stenosis in ischemic stroke patients with nonvalvular atrial fibrillation

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Neuropathology of white matter lesions in vascular cognitive impairment

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Elevated plasma homocysteine levels and risk of silent brain infarction in elderly people

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Total homocysteine is associated with white matter hyperintensity volume: the Northern Manhattan Study

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals. Correlations with plasma concentrations of naturally occurring antioxidants

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage: results of the Austrian Stroke Prevention Study

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Evaluation of genetic risk factors for silent brain infarction

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Correlation of NO metabolites and 8-iso-prostaglandin F2a with periventricular hyperintensity severity

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Nitric oxide synthase inhibition and cerebrovascular regulation

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

T-786C polymorphism in endothelial NO synthase gene affects cerebral circulation in smokers: possible gene-environmental interaction

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

ADMA increases arterial stiffness and decreases cerebral blood flow in humans

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Cardiovascular biology of the asymmetric dimethylarginine:dimethylarginine dimethylaminohydrolase pathway

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension : modulation of nitric oxide synthesis by salt intake

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Salt loading on plasma asymmetrical dimethylarginine and the protective role of potassium supplement in normotensive salt-sensitive asians

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Asymmetric dimethylarginine in cerebral small vessel disease

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Effects of some guanidino compounds on human cerebral arteries

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Endoscopic anatomy of the chordae willisii in the superior sagittal sinus

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Central and peripheral effects of asymmetric dimethylarginine, an endogenous nitric oxide synthetase inhibitor

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Homocysteine and atherothrombosis

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Total homocyst(e)ine concentration and the likelihood of nonfatal stroke: results from the Third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men.

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

The L-arginine paradox: Importance of the L-arginine/asymmetrical dimethylarginine ratio

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Elevatedl-Arginine/Dimethylarginine Ratio Contributes to Enhanced Systemic NO Production by Dietaryl-Arginine in Hypercholesterolemic Rabbits

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

An automated analyzer for methylated arginines in rat plasma by high-performance liquid chromatography with post-column fluorescence reaction

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

White matter signal abnormalities in normal individuals: correlation with carotid ultrasonography, cerebral blood flow measurements, and cerebrovascular risk factors

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Marked differences in prevalence of multiple sclerosis between ethnic groups in Oslo, Norway

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Symmetric dimethylarginine (SDMA) as endogenous marker of renal function--a meta-analysis

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Measurement of asymmetric dimethylarginine in plasma: methodological considerations and clinical relevance

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Asymmetric dimethylarginine (ADMA)--a modulator of nociception in opiate tolerance and addiction?

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Asymmetric dimethylarginine in homocystinuria due to cystathionine beta-synthase deficiency: relevance of renal function

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Homocysteine and cerebral ischemia: pathogenic and therapeutical implications

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Homocysteine and the kidney

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Two cardiovascular risk factors in one? Homocysteine and its relation to glomerular filtration rate. A meta-analysis of 41 studies with 27,000 participants

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Homocysteine hypothesis for atherothrombotic cardiovascular disease: not validated

1 reference

https://api.crossref.org/works/10.1038/AJH.2008.346

7 January 2021

Identifiers

DOI

10.1038/AJH.2008.346

1 reference

20 December 2017

1 reference

20 December 2017